Yatharth Hospital & Trauma Care Services Limited (NSE:YATHARTH)
India · Delayed Price · Currency is INR 636.55
-7.40 (-1.15%)
Aug 1, 2025, 3:29 PM IST
NSE:YATHARTH Revenue
In the fiscal year ending March 31, 2025, Yatharth Hospital & Trauma Care Services had annual revenue of 8.80B INR with 30.78% growth. Yatharth Hospital & Trauma Care Services had revenue of 2.32B in the quarter ending March 31, 2025, with 35.78% growth.
Revenue
8.80B
Revenue Growth
+30.78%
P/S Ratio
6.97
Revenue / Employee
1.68M
Employees
3,607
Market Cap
61.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 8.80B | 2.07B | 30.78% |
| Mar 31, 2024 | 6.73B | 1.51B | 28.85% |
| Mar 31, 2023 | 5.22B | 1.21B | 30.01% |
| Mar 31, 2022 | 4.02B | 1.73B | 75.74% |
| Mar 31, 2021 | 2.29B | 826.36M | 56.59% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Divi's Laboratories | 93.60B |
| Cipla | 274.80B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 129.10B |
| Zydus Lifesciences | 232.42B |
| Fortis Healthcare | 77.86B |
| Aurobindo Pharma | 317.24B |